Spinal cord injury (SCI) pain has a mixture of nociceptive and neuropathic etiologies. There are few controlled studies to guide medical therapy specifically for SCI pain, and so an extrapolation must be made from other painful conditions. This article attempts to establish a rational basis for the trial of pharmacologic agents as treatments for SCI pain. Pain localized to sites above the level of SCI should be approached and treated in an identical fashion to pain in patients without SCIs, with the recognition that some processes are common in SCI populations. Pain localized at or below the level of SCI is more complex, and treatment is more empiric with the use of nociceptive pain medications (anti-inflammatories and opioids) and neuropathic pain medications (e.g., antidepressants, anticonvulsants) directed by features suggestive of those types of pain. Relevant literature related to the treatment of nociceptive and neuropathic pains, in general, and SCI pain, in particular, is reviewed.
Skip Nav Destination
Article navigation
Research Article|
January 01 2001
Systemic Medications
Laura Kezar;
Laura Kezar
1
Assistant Professor, Department of Physical Medicine and Rehabilitation, University of Alabama at Birmingham
Search for other works by this author on:
Timothy Ness
Timothy Ness
2
Associate Professor, Department of Anesthesiology, University of Alabama at Birmingham
Search for other works by this author on:
Top Spinal Cord Inj Rehabil (2001) 7 (2): 57–72.
Citation
Laura Kezar, Timothy Ness; Systemic Medications. Top Spinal Cord Inj Rehabil 1 October 2001; 7 (2): 57–72. doi: https://doi.org/10.1310/3NJ7-V8XG-3WNJ-VMH3
Download citation file:
Citing articles via
Behavioral/Physical and Stimulation Interventions for Chronic Pain Following Spinal Cord Injury: A Systematic Review
Linda Ehrlich-Jones, PhD, RN, Elise Olsen, BA, Angelika Kudla, MS, Jennifer Burns, BA, Nicole Sharf, MA, Q. Eileen Wafford, MST, MLIS, Allen W. Heinemann, PhD
Grocery Shopping and Eating Behaviors Differ Between Persons With and Without a Spinal Cord Injury
Zachary J. Donato, MS, MD, Adam S. Levy, MS, MD, Alicia Sneij, PhD, MS, RD, Sherri L. LaVela, PhD, MPH, MBA, Arthur S. Berg, PhD, Lauren T. Shapiro, MD, MPH, Gary J. Farkas, PhD, MSCTI
No Beneficial Effects of the Alfasigma VSL#3 Probiotic Treatment After Cervical Spinal Cord Injury in Rats
Pamela J.F. Raposo, MSc, Antoinette T. Nguyen, PhD, Emma K.A. Schmidt, PhD, Abel Torres Espin, PhD, Keith K. Fenrich, PhD, David J. Bennett, PhD, Karim Fouad, PhD
Perspectives on Barriers to Use and Benefits of Functional Electrical Stimulation From Australians and New Zealanders With SCI and Clinicians and Researchers in the Field
Anne E. Palermo, PT, DPT, PhD, Edward Gorgon, PT, PhD, Antonio Vecchio, BS, Lisa Tedesco Triccas, PT, PhD, Euan McCaughey, PhD, Maggie Donovan-Hall, PhD
Breastfeeding After Spinal Cord Injury: A Systematic Review of Prevalence and Associated Complications
Andrei Krassioukov, MD, PhD, Amanda H.X. Lee, MSc, MD (student), Stacy Elliott, MD, Teri Thorson, Nathan Agon-Chen, BKin, MPT, MD, Gavin Naicker, BSc, MBT, MD (student), Matthew Querée, MAppPsych, Janice Eng, PhD, BSc(PT/OT), SCIRE Team